Rare condition
Hereditary sensory and autonomic neuropathy type 2
6
studies recruiting now
as of 7 Sept 2026
23
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
6 Aug 2026
most recent study posted
among recruiting studies
Recruiting trials
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
The Cancer of the Pancreas Screening-5 CAPS5)Study
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 6 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Hereditary sensory and autonomic neuropathy type 2 study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Hereditary sensory and autonomic neuropathy type 2
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (SCN9A, WNK1, RETREG1, KIF1A).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).